EP0205492A1 - Produit a base d'analgesiques, d'anti-inflammatoires et de decontractants musculaires transosseux - Google Patents

Produit a base d'analgesiques, d'anti-inflammatoires et de decontractants musculaires transosseux

Info

Publication number
EP0205492A1
EP0205492A1 EP19850906137 EP85906137A EP0205492A1 EP 0205492 A1 EP0205492 A1 EP 0205492A1 EP 19850906137 EP19850906137 EP 19850906137 EP 85906137 A EP85906137 A EP 85906137A EP 0205492 A1 EP0205492 A1 EP 0205492A1
Authority
EP
European Patent Office
Prior art keywords
composition
matter
skeletal muscle
muscle relaxant
xanthine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19850906137
Other languages
German (de)
English (en)
Inventor
Abraham Sunshine
Eugene M. Laska
Carole E. Siegel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0205492A1 publication Critical patent/EP0205492A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Abstract

Produits pharmaceutiques et leurs procédés d'utilisation, comprenant au moins un médicament anti-inflammatoire non stéroïde autre que l'aspirine, la paracétamol et la phénacétine, en combinaison avec au moins un décontractant musculaire transosseux, et éventuellement de la scanthine ou un de ses dérivés, tel que la caféine. La scanthine ou l'un de ses dérivés présente le double avantage de renforcer l'action du médicament anti-inflammatoire non stéroïde, et par son effet stimulant, de contrer l'effet sédatif du décontractant musculaire transosseux.
EP19850906137 1984-12-26 1985-11-27 Produit a base d'analgesiques, d'anti-inflammatoires et de decontractants musculaires transosseux Withdrawn EP0205492A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68638084A 1984-12-26 1984-12-26
US68637784A 1984-12-26 1984-12-26
US686380 1984-12-26
US686377 1984-12-26

Publications (1)

Publication Number Publication Date
EP0205492A1 true EP0205492A1 (fr) 1986-12-30

Family

ID=27103788

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19850906137 Withdrawn EP0205492A1 (fr) 1984-12-26 1985-11-27 Produit a base d'analgesiques, d'anti-inflammatoires et de decontractants musculaires transosseux

Country Status (4)

Country Link
EP (1) EP0205492A1 (fr)
AU (1) AU582513B2 (fr)
CA (1) CA1261753A (fr)
WO (1) WO1986003681A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735369B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
AU3990895A (en) * 1995-12-05 1997-06-27 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US20040204413A1 (en) * 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
US6562980B1 (en) * 2002-08-19 2003-05-13 Yung Shin Pharma Ind. Co., Ltd. Method for producing 5-aryloxymethyl-2-oxazolidinones
MXPA05010506A (es) * 2005-09-29 2007-03-28 Leopoldo Espinosa Abdala Forma farmaceutica para el tratamiento de casos agudos y exacerbaciones de pacientes con artritis reumatoide, y transtornos agudos relacionados.
WO2008054188A1 (fr) * 2006-10-30 2008-05-08 Farmacéuticos Rayere, S.A. Composition pharmaceutique synergique de carisoprodol et de clonixinate de lysine
WO2008109018A1 (fr) * 2007-03-02 2008-09-12 Meda Pharmaceuticals Inc. Compositions comprenant du carisoprodol, et leurs procédés d'utilisation
TR200703092A1 (tr) 2007-05-08 2008-12-22 SANOVEL �LA� SAN. VE TiC. A.�. Flurbiprofen ve kas gevşetici kombinasyonları
TR200708925A1 (tr) * 2007-12-26 2009-07-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Kontrollü salım sağlayan flurbiprofen ve kas gevşetici kombinasyonları
GB2478931B (en) * 2010-03-23 2013-06-12 John Paul Kelly Use of caffeine and aspirin in synergistic amounts for improving performance in sporting activity
BRPI1103205A2 (pt) * 2011-06-03 2014-02-25 Eurofarma Lab Ltda Composição farmacêutica oral e uso da composição farmacêutica oral
ES2582878T3 (es) 2013-09-12 2016-09-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Formulación farmacéutica que comprende una combinación de un relajante muscular y un analgésico
US20170189374A1 (en) 2014-07-21 2017-07-06 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Zaltoprofen and muscle relaxant combinations
CA2994752A1 (fr) * 2015-08-05 2017-02-09 Synergistic Therapeutics, Llc Lotion analgesique topique
DE102020106223A1 (de) 2020-03-06 2021-09-09 Mohammad Amin Jahan Panah Schmerzmedikament
DE102019112208B4 (de) * 2019-05-09 2021-10-28 Mohammad Amin Jahan Panah Schmerzmedikament
DE112020002320A5 (de) 2019-05-09 2022-01-27 Mohammad Amin Jahan Panah Schmerzmedikament

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8603681A1 *

Also Published As

Publication number Publication date
AU5198186A (en) 1986-07-22
CA1261753A (fr) 1989-09-26
AU582513B2 (en) 1989-03-23
WO1986003681A1 (fr) 1986-07-03

Similar Documents

Publication Publication Date Title
AU582513B2 (en) Method for using musculoskeletal relaxants
US4923898A (en) Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
US4780463A (en) Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
EP0114886B1 (fr) Compositions analgesiques et anti-inflammatoires ameliorees comprenant de la cafeine
CA1251137A (fr) Composes analgesiques et anti-inflammatoires contenant de la diphenhydramine et methodes d'utilisation
CA1327315C (fr) Compositions contre la toux et le rhume contenant des antihistaminiques sous effet sedatif
US4722938A (en) Methods for using musculoskeletal relaxants
JP6251321B2 (ja) Ｄｇａｔ１阻害剤の使用
US20030008925A1 (en) Treatment of drug-induced sleepiness
JPS61500666A (ja) キサンチン類を含んでなる鎮痛および抗炎症組成物およびその使用法
KR20070073881A (ko) 니코틴성 아세틸콜린 알파 ７ 수용체 아고니스트의 조합물
JP2004518653A (ja) 不安障害を治療する方法
US4464376A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4420483A (en) Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4656177A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
CA1217429A (fr) Compositions analgesiques et anti-inflammatoires a teneur de cafeine, et leur mode d'emploi
US4683243A (en) Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
ES2879993T3 (es) Agente preventivo o terapéutico para el dolor asociado al herpes zoster en fase aguda
TWI304735B (en) Carbamate compounds for use in the treatment of pain
US4587249A (en) Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
Playfer Parkinson's disease
Cooper Ketoprofen in oral surgery pain: a review
GB2259013A (en) Neuroprotective use of CCK antagonists
TORNETTA Double-blind evaluation of haloperidol for antiemetic activity
WO2001045698A1 (fr) Therapie combinee pour le traitement de maladie neurodegenerative

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19860818

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19880818

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19900727